Chonnam National University Hospital Showcases Outstanding Technologies at BIO KOREA 2022

[Asia Economy Honam Reporting Headquarters Reporter Yoon Jamin] The open laboratory at Chonnam National University Hospital recently participated in BIO KOREA 2022, Korea's representative biohealth industry convention held at COEX in Seoul, showcasing excellent technologies and products.

Celebrating its 17th edition this year, BIO KOREA 2022 was held offline following the lifting of social distancing measures, with over 700 companies from 50 countries participating.

Four companies participating in the Chonnam National University Hospital open laboratory?Newlive Co., Ltd., Neurogen Co., Ltd., Kims Bio Co., Ltd., and Biot Korea Co., Ltd.?presented four outstanding health care technologies and products developed through collaboration between the hospital and startup companies.

At this event, Newlive Co., Ltd. introduced ‘SoriCle’, a treatment for tinnitus that improves cerebral plasticity and brain function activation through non-invasive electrical and sound stimulation of the vagus nerve. Neurogen Co., Ltd. showcased ‘NeuroAI’, a solution for predicting amyloid PET positivity through combined analysis of brain imaging and APOE genotype.

Kims Bio Co., Ltd. presented surgical clips ‘Cure Lock’ used for hemostasis of blood vessels and tissues during surgery, as well as ‘D-Cure Fix Plus’ and ‘Drain Fix’ products that enhance the fixation strength of drainage tubes.

Biot Korea Co., Ltd. introduced ‘Stem Cell Navigator’, a cell therapy device for fundamental treatment of joint and nervous system diseases, and the ‘RAPIDS Platform’, a robot-based system designed to meet the demand for specimen collection and non-face-to-face medical care including PCR testing amid the COVID-19 pandemic.

Project Director Cho Hyun-ho (Professor of Otorhinolaryngology) stated, “Based on close clinical consulting, we will strengthen networking with existing research and development teams and maximize the use of hospital infrastructure to invigorate joint research and technology development between hospitals and companies, thereby maximizing outcomes.”

The Chonnam National University Hospital project team jointly operated the BIO KOREA open laboratory exhibition hall with teams from Dongguk University Ilsan Hospital, Ajou University Hospital, Busan Paik Hospital, Korea University Guro Hospital, Ewha Mokdong Hospital, and Gyeongsang National University Hospital. They also donated 10,000 KF-94 masks and sterilized disinfectants to social service organizations to help socially vulnerable groups such as elderly living alone and low-income families overcome COVID-19.

Meanwhile, the Chonnam National University Hospital open laboratory construction project aims to revitalize the biomedical industry based on joint research between hospitals and companies by establishing an open innovation platform within hospitals with excellent research capabilities and infrastructure. Chonnam National University Hospital was selected as the lead institution for the ‘Open Laboratory Construction Project’ again in 2022 following 2019, and is currently advancing the first year of the second phase of the project.

This content was produced with the assistance of AI translation services.